Preclinical evaluation of B7-H3–specific chimeric antigen receptor T cells for the treatment of acute myeloid leukemia

EI Lichtman, H Du, P Shou, F Song, K Suzuki… - Clinical Cancer …, 2021 - AACR
Purpose: The development of safe and effective chimeric antigen receptor (CAR) T-cell
therapy for acute myeloid leukemia (AML) has largely been limited by the concomitant …
被引用次数：64 相关文章

Preclinical Evaluation of B7-H3-specific Chimeric Antigen Receptor T Cells for the Treatment of Acute Myeloid Leukemia

EI Lichtman, H Du, P Shou, F Song… - … : an official journal …, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose The development of safe and effective chimeric antigen receptor (CAR) T-cell
therapy for acute myeloid leukemia (AML) has largely been limited by the concomitant …
[HTML] nih.gov

[HTML][HTML] Preclinical Evaluation of B7-H3-Specific Chimeric Antigen Receptor T cells for the Treatment of Acute Myeloid Leukemia

E Lichtman, H Du, P Shou, F Song… - … cancer research: an …, 2021 - ncbi.nlm.nih.gov
Purpose: The development of safe and effective CAR T cell therapy for acute myeloid
leukemia (AML) has largely been limited by the concomitant expression of most AML …
[PDF] archive.org

[PDF][PDF] Preclinical Evaluation of B7-H3-Specific Chimeric Antigen Receptor T cells for the Treatment of Acute Myeloid Leukemia

E Lichtman, H Du, P Shou, F Song, K Suzuki… - Clin Cancer …, 2021 - scholar.archive.org
Purpose: The development of safe and effective CAR T cell therapy for acute myeloid
leukemia (AML) has largely been limited by the concomitant expression of most AML …

Preclinical Evaluation of B7-H3-specific Chimeric Antigen Receptor T Cells for the Treatment of Acute Myeloid Leukemia.

EI Lichtman, H Du, P Shou, F Song… - … Cancer Research: an …, 2021 - europepmc.org
Purpose The development of safe and effective chimeric antigen receptor (CAR) T-cell
therapy for acute myeloid leukemia (AML) has largely been limited by the concomitant …

Preclinical evaluation of B7-H3-specific chimeric antigen receptor T cells for the treatment of acute myeloid leukemia

EI Lichtman, H Du, P Shou, F Song, K Suzuki… - Clinical Cancer …, 2021 - cdr.lib.unc.edu
Purpose: The development of safe and effective chimeric antigen receptor (CAR) T-cell
therapy for acute myeloid leukemia (AML) has largely been limited by the concomitant …